Aptose Biosciences

-$0.04 (-1.79%) Today
+$0.03 (+1.37%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell APTO and other ETFs, options, and stocks.

About APTO

Aptose Biosciences, Inc. is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. Its product pipeline includes APTO-253, a small molecule that induces expression of the Kruppel-Like Factor 4 genes; and CG-806 a non-covalent small molecule therapeutic agent.

CEO
William G. Rice
Employees
39
Headquarters
Toronto, Ontario
Founded
1986

APTO Key Statistics

Market Cap
196.26M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
809.72K
High Today
$2.21
Low Today
$2.14
Open Price
$2.20
Volume
407.87K
52 Week High
$7.27
52 Week Low
$2.11

APTO Earnings

-$0.21
-$0.14
-$0.07
-$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 9, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure